Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-23 Purchase |
2023-06-26 4:26 pm |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
12,787 | $3.91 | $49,997 | 29,943 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-03 4:15 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
5,290 | $5.34 | 44,608 (Direct) |
View |
| 2024-06-01 Option Award |
2024-06-03 4:35 pm |
N/A 2034-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
28,472 | $0 | 67,790 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-02 5:05 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
9,375 | $2.8 | 39,318 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:33 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
16,968 | $0 | 34,124 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-03 4:25 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
17,156 | $1.53 | 17,156 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 4:34 pm |
N/A 2032-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
13,222 | $0 | 13,222 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-16 4:21 pm |
N/A 2031-07-14 |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
18,786 | $0 | 18,786 (Direct) |
View |